The study, to be published in today’s online version of the journal Pediatrics, is the first such trial to be conducted in accordance with U.S. Food and Drug Administration guidelines. Previous studies had found that nasal corticosteroids had no impact on children’s growth, but those clinical trials had design flaws that produced conflicting results, leading to the new FDA guidelines followed in the AHN study. Oftentimes a child is treated with inhaled steroids for asthma as well as nasal steroids for nasal allergies, which can compromise growth development and result in life-threatening adrenal gland suppression. There have not been many studies conducted on the outcome of using two steroids. “There are a lot of steroids being used by children, many with combined nasal and lung administration, so there is a great need for education by doctors and patients,” Dr. Skoner said.
Posted on: Tue, 27 Jan 2015 01:22:52 +0000
Trending Topics
Recently Viewed Topics
© 2015